Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record for the abrocitinib-versus-dupilumab trial is displayed with detailed study information, publications, participant data-sharing details, and downloadable study documents.
    Difference
    100%
    Check dated 2026-11-10T19:53:48.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-11-03T20:12:32.000Z thumbnail image
  3. Check
    25 days ago
    Change Detected
    Summary
    A general NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:46:16.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The footer revision marker changed from v3.7.0 to v3.7.1 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-06T19:47:23.000Z thumbnail image
  5. Check
    53 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error instead of the study record content, removing access to the NCT04345367 trial details and locations. This replaces the prior study information with an error page, affecting how users can view or reference this trial on ClinicalTrials.gov.
    Difference
    18%
    Check dated 2026-09-22T21:49:50.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.6 to v3.7.0, indicating a minor update to the page system or content without changing the study information.
    Difference
    0.0%
    Check dated 2026-09-15T21:46:04.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.